In the dose-escalation phase of our study , patients received vemurafenib @ mg or @ mg twice a day continuously and cobimetinib @ mg , @ mg , or @ mg once a day for either @ days on and @ days off ( @/@ ) , @ days on and @ days off ( @/@ ) , or continuously ( @/@ ) .